<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6549162</article-id><article-id pub-id-type="publisher-id">44699</article-id><article-id pub-id-type="doi">10.1038/s41598-019-44699-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association of <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> cluster polymorphism in 11q23.3 and structure of APOA5 with increased plasma triglyceride levels in a Korean population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Han-Kyul</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8794-5589</contrib-id><name><surname>Anwar</surname><given-names>Muhammad Ayaz</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Choi</surname><given-names>Sangdun</given-names></name><address><email>sangdunchoi@ajou.ac.kr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0532 3933</institution-id><institution-id institution-id-type="GRID">grid.251916.8</institution-id><institution>Department of Molecular Science and Technology, </institution><institution>Ajou University, </institution></institution-wrap>Suwon, 16499 Korea </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>6</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>6</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>9</volume><elocation-id>8296</elocation-id><history><date date-type="received"><day>15</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>22</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">In this association study on chromosome 11, the data from 12,537 Korean individuals within the Health Examinee (HEXA) and the Korea Association Resource (KARE) projects were analysed to identify genetic loci correlating with increased and decreased plasma triglyceride (TG) levels. We identified a locus in chromosomal region 11q23.3 that harbours genes <italic>BUD13</italic>, <italic>ZNF259</italic>, <italic>APOA5</italic>, <italic>APOA1</italic>, and <italic>SIK3</italic>, which may be associated with plasma TG levels. In this locus, 13 relevant single-nucleotide polymorphisms (SNPs) were found: rs184616707, rs118175510, rs60954647, rs79408961, and rs180373 (near <italic>BUD13</italic>); rs11604424 (in <italic>ZNF259</italic>); rs2075291, rs651821, and rs7123666 (in or near <italic>APOA5</italic>); rs525028 (near <italic>APOA1</italic>), and rs645258, rs10160754, and rs142395187 (in or near <italic>SIK3</italic>). All 13 SNPs satisfied the genome-wide significance level (P&#x02009;&#x0003c;&#x02009;5.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>) in both meta-analysis and conditional analysis. Haplotype analysis of six SNPs (rs79408961, rs180373, rs2075291, rs651821, rs525028, and rs10160754) that were selected based on the &#x003b2; coefficient and conditional <italic>P</italic> values, revealed nine common haplotypes (with frequency 0.02&#x02013;0.34) associated with both increased and reduced TG levels. Furthermore, to shed light on possible structural implications, we modelled and simulated the G185C variant of APOA5 (corresponding to rs2075291), which showed the strongest association. Molecular dynamics simulation results showed that this polymorphic variant of APOA5 has a different hydrogen bond network, increased average distance between chains, and an ability to form distinct clusters. Owing to the orientation of cysteine, the possibility of disulphide bond formation with other proteins is evident. In summary, our association and modelling analyses provided evidence that genetic variations in chromosomal region 11q23.3 are associated with elevated TG levels.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Data mining</kwd><kwd>Genome informatics</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea (NRF)</institution></institution-wrap></funding-source><award-id>2019R1H1A2039674</award-id><principal-award-recipient><name><surname>Choi</surname><given-names>Sangdun</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Commercializations Promotion Agency for R&#x00026;amp;D Outcomes funded by the Ministry of Science and ICT (2018K000369)</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Plasma triglyceride (TG) levels play a significant role in metabolic disorders, including insulin resistance, hyperglycaemia, hypertension, and obesity<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Plasma TG levels are influenced by environmental as well as heritable factors<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>; the latter are associated with an increased risk of cardiovascular diseases<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Through a series of processes, TGs are usually secreted from the liver as very low-density lipoprotein (VLDL) particles, which are composed of TG, cholesterol, phosphatidylcholine, and apolipoprotein<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Approximately 50% of VLDL particles are transferred into the cell through receptor-mediated endocytosis via interactions between apolipoprotein E and low-density lipoprotein receptors<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. In addition, apolipoprotein A5 (APOA5), which belongs to the apolipoprotein family, plays a pivotal role in TG level regulation and typically reduces VLDL production<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Van der Vliet <italic>et al</italic>. have demonstrated that mice overexpressing APOA5 show a 70% reduction in the TG level as compared with wild-type (WT) mice<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. This reduction in plasma TG concentration is attributed to changes in VLDL turnover<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. In contrast, <italic>APOA5</italic> knockout mice have a plasma TG level four-fold higher than that of control mice<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. This observation suggests that APOA5 affects plasma TG levels, and that dysfunction of <italic>APOA5</italic> may be a risk factor of hypertriglyceridaemia<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p><p id="Par3">Some genome-wide association studies (GWASs) have revealed that genetic variants can significantly increase plasma TG levels, and <italic>APOA5</italic> and lipoprotein lipase are well known TG-related genes<sup><xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref></sup>. Furthermore, in the Chinese Han population, the rs651821 polymorphism in <italic>APOA5</italic> is strongly associated with plasma TG levels<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>; and in 2015, 41 additional loci in Europeans were associated with TG levels through GWASs<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>.</p><p id="Par4">Various GWAS findings have indicated that the <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> gene cluster in the 11q23.3 chromosomal region is strongly involved in TG metabolism<sup><xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref></sup>. Therefore, in this study, we investigated the <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> gene cluster in a Korean population, and found 13 SNPs, which span 465 kbp. In the 11q23.3 region, we then determined the effects of haplotype variants. To this end, we obtained access to the data on Korean cohorts, the HEXA (Health Examinee) study (discovery study) and KARE (Korea Association Resource) study (replication study), and performed statistical analysis. We found that the G185C variant of APOA5 has the strongest association with TG levels in this combined cohort of Korean population. Furthermore, to supplement our experimental data, various computational approaches were used including molecular modelling and molecular dynamics (MD) simulations. Accordingly, we created a homology model for G185C in APOA5 (rs2075291), the only SNP with the highest probability to be expressed and to cause the G185C substitution in APOA5, whereas the other SNPs are located in non-protein-coding regions. Finally, the models were subjected to MD simulations to lend support to our genetic findings.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><p id="Par5">The overall study design is presented in Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>. The general characteristics of the study participants are provided in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The mean TG levels were higher in KARE participants (162.9&#x02009;mg/dl) than in HEXA participants (123.3&#x02009;mg/dl).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics in the discovery (HEXA) study and replication (KARE) study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Discovery (HEXA)</th><th>Replication (KARE)</th><th>P value</th></tr></thead><tbody><tr><td>No. of subjects</td><td>3,689</td><td>8,834</td><td/></tr><tr><td>Males, n (%)</td><td>1,646 (44.6)</td><td>4,176 (47.3)</td><td>0.006</td></tr><tr><td>Age, y<sup>&#x003b1;</sup></td><td>53.2&#x02009;&#x000b1;&#x02009;8.3</td><td>52.2&#x02009;&#x000b1;&#x02009;8.9</td><td>&#x0003c;0.001</td></tr><tr><td>Body mass index, kg/m<sup>2</sup></td><td>24.0&#x02009;&#x000b1;&#x02009;2.9</td><td>24.6&#x02009;&#x000b1;&#x02009;2.9</td><td>&#x0003c;0.001</td></tr><tr><td>TG, mg/dl</td><td>123.3&#x02009;&#x000b1;&#x02009;90.6</td><td>162.9&#x02009;&#x000b1;&#x02009;105.7</td><td>&#x0003c;0.001</td></tr><tr><td>Fasting glucose, mg/dl</td><td>94.1&#x02009;&#x000b1;&#x02009;24.6</td><td>87.7&#x02009;&#x000b1;&#x02009;21.9</td><td>&#x0003c;0.001</td></tr><tr><td>TCHL, mg/dl</td><td>197.5&#x02009;&#x000b1;&#x02009;35.0</td><td>191.6&#x02009;&#x000b1;&#x02009;36.0</td><td>&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><p><sup>&#x003b1;</sup>Data are shown as mean&#x02009;&#x000b1;&#x02009;standard deviation.</p><p>TG, Triglyceride; TCHL, Total cholesterol.</p></table-wrap-foot></table-wrap></p><p id="Par6">To find gene associations with plasma TG levels among these Korean participants, the data from these studies were subjected to various analyses. As a result, a locus (<italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic>) in chromosomal region 11q23.3 was found to be associated with TG levels. When we analysed chromosome 11 using a mixed-linear model, a total of 426 SNPs satisfied the genome-wide significance level (<italic>P</italic>&#x02009;&#x0003c;&#x02009;5.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>) after meta-analysis with the replication study, and all these 426 SNPs are located in the 11q23.3 region (Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). Next, we performed conditional analysis on these 426 SNPs and as a result only 13 SNPs remained (<italic>P</italic>&#x02009;&#x0003c;&#x02009;5.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>). Out of these 13 SNPs in the <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> gene cluster, five SNPs were near <italic>BUD13</italic>; one SNP was in <italic>ZNF259</italic>; three SNPs were in or near <italic>APOA5</italic>; one SNP was near <italic>APOA1</italic>; and three SNPs were in or near <italic>SIK3</italic>.rs651821 was found to have the highest statistical significance (combined <italic>P</italic>&#x02009;=&#x02009;4.91&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;100</sup>). Relevant details for these SNPs, including neighbouring genes, SNP ID, chromosomal position, minor allele frequency (MAF), the effect allele, and effect sizes are provided in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>A summary of SNPs related to significant variants in the discovery (HEXA) and replication (KARE) studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Nearby<break/>Gene<sup>a</sup></th><th rowspan="2">SNP ID</th><th rowspan="2">Class</th><th rowspan="2">Position<sup>b</sup></th><th rowspan="2">Effect allele<sup>c</sup></th><th colspan="2">Discovery (HEXA) study</th><th colspan="3">Trend <italic>P</italic> value<sup>d</sup></th><th rowspan="2">Conditional<break/><italic>P</italic> value</th><th rowspan="2">Beta of<break/>combination</th></tr><tr><th>MAF</th><th>Beta</th><th>HEXA<break/>(<italic>n</italic>&#x02009;=&#x02009;3,689)</th><th>Replication<break/>study<break/>(KARE)<break/>(<italic>n</italic>&#x02009;=&#x02009;8,834)</th><th>Combined<break/>(<italic>n</italic>&#x02009;=&#x02009;12,535)</th></tr></thead><tbody><tr><td>BUD13</td><td>rs184616707</td><td>NearGene-3</td><td>116510558</td><td>G</td><td>0.02</td><td>35.52</td><td>5.49E-05</td><td>1.85E-05</td><td>4.13E-09</td><td>2.47E-13</td><td>34.11</td></tr><tr><td>BUD13</td><td>rs118175510</td><td>NearGene-3</td><td>116532548</td><td>C</td><td>0.10</td><td>9.10</td><td>9.91E-03</td><td>6.74E-08</td><td>5.22E-09</td><td>2.50E-10</td><td>12.71</td></tr><tr><td>BUD13</td><td>rs60954647</td><td>NearGene-3</td><td>116566933</td><td>T</td><td>0.47</td><td>&#x02212;7.49</td><td>3.79E-04</td><td>4.29E-08</td><td>7.34E-11</td><td>5.13E-143</td><td>&#x02212;8.28</td></tr><tr><td>BUD13</td><td>rs79408961</td><td>NearGene-3</td><td>116588593</td><td>T</td><td>0.07</td><td>13.12</td><td>9.67E-04</td><td>2.05E-16</td><td>1.01E-17</td><td>1.06E-144</td><td>20.23</td></tr><tr><td>BUD13</td><td>rs180373</td><td>NearGene-3</td><td>116591553</td><td>A</td><td>0.10</td><td>&#x02212;9.12</td><td>8.53E-03</td><td>5.09E-09</td><td>3.28E-10</td><td>2.53E-68</td><td>&#x02212;12.65</td></tr><tr><td>ZNF259</td><td>rs11604424</td><td>Intron</td><td>116651115</td><td>C</td><td>0.49</td><td>7.44</td><td>2.80E-04</td><td>2.53E-11</td><td>7.13E-14</td><td>1.56E-178</td><td>9.52</td></tr><tr><td>APOA5</td><td>rs2075291</td><td>Missense</td><td>116661392</td><td>A</td><td>0.07</td><td>37.11</td><td>6.46E-21</td><td>8.30E-48</td><td>9.60E-67</td><td>7.91E-109</td><td>40.53</td></tr><tr><td>APOA5</td><td>rs651821</td><td>Intron</td><td>116662579</td><td>C</td><td>0.29</td><td>23.46</td><td>9.61E-26</td><td>1.98E-78</td><td>4.91E-100</td><td>8.57E-213</td><td>29.25</td></tr><tr><td>APOA5</td><td>rs7123666</td><td>NearGene-5</td><td>116667083</td><td>A</td><td>0.14</td><td>12.80</td><td>2.17E-05</td><td>3.60E-15</td><td>9.29E-19</td><td>4.35E-14</td><td>15.99</td></tr><tr><td>APOA1</td><td>rs525028</td><td>NearGene-3</td><td>116705516</td><td>A</td><td>0.25</td><td>&#x02212;8.51</td><td>4.00E-04</td><td>7.64E-07</td><td>1.26E-09</td><td>5.29E-90</td><td>&#x02212;9.11</td></tr><tr><td>SIK3</td><td>rs645258</td><td>Intron</td><td>116801201</td><td>A</td><td>0.29</td><td>4.87</td><td>2.96E-02</td><td>1.36E-10</td><td>2.08E-10</td><td>2.82E-14</td><td>8.96</td></tr><tr><td>SIK3</td><td>rs10160754</td><td>Intron</td><td>116858994</td><td>C</td><td>0.14</td><td>&#x02212;9.60</td><td>1.47E-03</td><td>5.64E-08</td><td>4.38E-10</td><td>1.52E-78</td><td>&#x02212;11.54</td></tr><tr><td>SIK3</td><td>rs142395187</td><td>NearGene-5</td><td>116976009</td><td>G</td><td>0.12</td><td>&#x02212;13.10</td><td>1.07E-04</td><td>9.69E-09</td><td>5.18E-12</td><td>2.52E-13</td><td>&#x02212;14.52</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Nearby genes are defined as the closest genes to the SNP within signal boundary or the closest genes within a 200-kb window.</p><p><sup>b</sup>Chromosomal positions are based on the 1000 Genomes Project&#x02019;s haplotype phase I in NCBI build 37 (hg19).</p><p><sup>c</sup>The minor allele is the effect allele.</p><p><sup>d</sup>The P value for the effects of genotypes on plasma TG levels were assessed via a mixed linear model with adjustment for age, sex, and body&#x02013;mass index (BMI).</p></table-wrap-foot></table-wrap></p><p id="Par7">The linkage disequilibrium (LD) matrix pattern among the 13 markers in the 11q23.3 region is presented in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. LD profiles of the 13 markers found in the combined Korean population were comparable with those of Chinese and Japanese (CHB/JPT) populations but differed from those of Europeans (CEU). The rest of the SNPs were in weak LD (r<sup>2</sup>&#x02009;&#x0003c;&#x02009;0.30), whereas rs10160754 and rs142395187 (r<sup>2</sup>&#x02009;=&#x02009;0.46, in the combined Korean population) were the exceptions.<fig id="Fig1"><label>Figure 1</label><caption><p>LDlink matrix patterns among the 13 SNP targets in Korean, Chinese, Japanese, and European populations. Genes present in chromosomal region 11q23.3 include <italic>BUD13</italic>, <italic>ZNF259</italic>, <italic>APOA5</italic>, <italic>APOA1</italic>, and <italic>SIK3</italic>. Pairwise LD values between the SNPs are described by white-red and blue shading; r<sup>2</sup>&#x02009;=&#x02009;0 is represented by the white colour, r<sup>2</sup>&#x02009;=&#x02009;1 is represented by red, and blue denotes intermediate LD.</p></caption><graphic xlink:href="41598_2019_44699_Fig1_HTML" id="d29e1252"/></fig></p><p id="Par8">Among the 13 SNPs, only eight SNPs satisfied the conditional P value (<italic>P</italic>&#x02009;&#x0003c;&#x02009;2.5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;68</sup>). From these eight SNPs, we selected six SNPs: three with the highest and three with the lowest &#x003b2; coefficients. Next, to test whether the six selected SNPs have any association with plasma TG levels, we conducted a haplotype analysis on the selected SNPs; haplotypes with &#x0003c;1% frequency were excluded from further analyses. Nine haplotypes were obtained, and the details are shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. When the most common CCCTGA haplotype was used as a reference, the other three haplotypes, CCACGA (&#x003b2;&#x02009;=&#x02009;44.25, <italic>P</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;5</sup>), TCACGA (&#x003b2;&#x02009;=&#x02009;40.10, <italic>P</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;5</sup>), and CCCCGA (&#x003b2;&#x02009;=&#x02009;17.82, <italic>P</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;5</sup>) showed a significant correlation, whereas one haplotype was only marginally associated with TG levels. In contrast, the other four haplotypes showed a weak association with lower TG levels in the combined Korean population.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Association of the haplotypes involving the six SNPs in the Korean populations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>rs79408961<break/>(<italic>BUD13</italic>)</th><th>rs180373<break/>(<italic>BUD13</italic>)</th><th>rs2075291<break/>(<italic>APOA5</italic>)</th><th>rs651821<break/>(<italic>APOA5</italic>)</th><th>rs525028<break/>(<italic>APOA1</italic>)</th><th>rs10160754<break/>(<italic>SIK3</italic>)</th><th>Haplotype<break/>Frequencies</th><th>&#x003b2; coefficient</th><th>
<italic>P</italic>
</th></tr></thead><tbody><tr><td>C</td><td>C</td><td>A</td><td>C</td><td>G</td><td>A</td><td>0.02</td><td>44.25</td><td>&#x0003c;1.00E-05</td></tr><tr><td>T</td><td>C</td><td>A</td><td>C</td><td>G</td><td>A</td><td>0.04</td><td>40.10</td><td>&#x0003c;1.00E-05</td></tr><tr><td>C</td><td>C</td><td>C</td><td>C</td><td>G</td><td>A</td><td>0.20</td><td>17.82</td><td>&#x0003c;1.00E-05</td></tr><tr><td>C</td><td>C</td><td>C</td><td>T</td><td>A</td><td>A</td><td>0.15</td><td>0.34</td><td>2.09E-02</td></tr><tr><td>C</td><td>C</td><td>C</td><td>T</td><td>G</td><td>A</td><td>0.34</td><td>Reference</td><td>6.00E-05</td></tr><tr><td>C</td><td>C</td><td>C</td><td>T</td><td>G</td><td>C</td><td>0.05</td><td>&#x02212;2.88</td><td>1.86E-02</td></tr><tr><td>C</td><td>A</td><td>C</td><td>T</td><td>G</td><td>A</td><td>0.06</td><td>&#x02212;5.11</td><td>1.34E-02</td></tr><tr><td>C</td><td>C</td><td>C</td><td>T</td><td>A</td><td>C</td><td>0.04</td><td>&#x02212;7.05</td><td>6.01E-03</td></tr><tr><td>T</td><td>C</td><td>C</td><td>T</td><td>A</td><td>C</td><td>0.02</td><td>&#x02212;8.27</td><td>3.40E-02</td></tr></tbody></table></table-wrap></p><p id="Par9">Next, we determined whether allelic dosage of risk haplotypes containing the six SNPs contributed to quantitative diversity in plasma TG levels of the 3,689 individuals from the HEXA study. As shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, plasma TG levels were evaluated according to haplotypes. Plasma TG levels were significantly higher in people with haplotype CCACGA, TCACGA, or CCCCGA (<italic>P</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;3</sup>). The other five haplotypes showed no correlation with plasma TG levels as compared with those of controls.<fig id="Fig2"><label>Figure 2</label><caption><p>Plasma TG levels in people with haplotypes containing the six SNPs. A box plot of plasma TG levels in people with the identified haplotypes. Outliers are indicated by small circles, far outliers are not shown in this figure.</p></caption><graphic xlink:href="41598_2019_44699_Fig2_HTML" id="d29e1636"/></fig></p><p id="Par10">Among the polymorphisms, the only SNP that can cause an amino acid substitution in a protein is rs2075291 (in APOA5). This SNP can result in G185C substitution, where the addition of cysteine can potentially provide an opportunity for formation of new disulphide bond with other proteins. In addition to the possibility of a disulphide bond, this mutation can decrease the protein&#x02019;s flexibility and can rearrange its three-dimensional (3D) structure resulting in an altered conformational ensemble. The altered state of protein conformation can significantly change its functional characteristics. To test this hypothesis, a homology model was created, and docking was performed for dimerisation of APOA5. The resultant dimer showed that C185 faces outward, and the relative positions of neighbouring C185s are too far from each other for possible disulphide bond formation. Similarly, C185 was unable to form a disulphide bond with C227 (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). This result suggested that the probability of disulphide bond formation between these monomers is low, unless they slide along in the opposite directions to ensure the proper distance needed for bond formation. Nevertheless, due to the easily accessible -SH group in this model, it is highly likely that a disulphide bond will form between a dimer of APOA5 and other interacting proteins, such as kininogen-1 and fibronectin<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. This additional bond formation may result in a loss of function or an unusual multimeric complex. Moreover, the individual monomers in this APOA5 dimer model are antiparallel, and thus can snugly fit into each other to support the dimer formation.</p><sec id="Sec3"><title>Structural modelling of polymorphic APOA5</title><p id="Par11">To verify these findings and to evaluate the structural features APOA5, MD simulations were performed on APOA5-WT and APOA5-MUT (G185C). These dimeric molecules either appeared to be stable when analysed using root mean-squared deviation (RMSD) and radius of gyration (Rg) or acquired stability later during simulations (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S3A,B</xref>). These systems showed more variability in the initial phase of MD simulations, and variability was also evident within the same system. With time, however, the systems reached an equilibrium and converged to similar values. Readers should take into account the chaotic nature of MD simulations where even the same system can evolve to different conformation. The per residue fluctuation data also provided interesting insights: APOA5-WT showed greater fluctuation than APOA5-MUT did (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The results indicated that APOA5-WT is more flexible than the polymorphic form of APOA5, and such structural confinement may be due to the presence of C185. This finding is expected because glycine is a flexible residue with hydrogen as a side chain, protein regions with glycine usually form loop structures due to its flexibility. When glycine is replaced with cysteine, protein region becomes more rigid<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.<fig id="Fig3"><label>Figure 3</label><caption><p>The residual fluctuation of APOA5 complexes. RMSF was calculated to monitor the amino acid mobility. The WT complex (black curve) manifested greater fluctuation along its length as compared to the mutant (red). RMSF is the average of last 10&#x02009;ns of two independent simulations; a standard deviation in the respective colours is presented too. The monomeric part of this homodimeric complex is indicated by an arrow along the X-axis.</p></caption><graphic xlink:href="41598_2019_44699_Fig3_HTML" id="d29e1669"/></fig></p><p id="Par12">Secondary structures of the protein remained largely intact throughout the simulation when analysed through dictionary of secondary structure of proteins. No substantial changes were observed in any secondary structure classes; however, minor alterations were expected (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>).</p><p id="Par13">The numbers of hydrogen bonds (H-bonds) within and between the monomer were significantly different between the WT and mutant protein. APOA5-WT contained lower numbers of inter- and intra-protein H-bonds as compared with APOA5-MUT. These data were suggestive of structural differences between the APOA5-WT and mutant APOA5 protein. The detailed analysis of H-bonds was performed on the average structure of the last nanosecond of each trajectory, and it was found that these H-bonds are scattered along the helical length of the APOA5 protein (Table&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>). Mover, solvent-accessible surface area (SASA) also turned out to be larger in APOA5-WT, suggesting that the WT protein has greater solvent exposure (Figs&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="MOESM1" ref-type="media">S5</xref>). APOA5 has a long helical structure that fluctuated during the simulation; therefore, the angle along the helical length was calculated to determine the magnitude of protein bending. APOA5-WT showed slightly more bending than APOA5-MUT did, indicating that the G185C substitution in APOA5 stiffens protein structure (Figs&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="MOESM1" ref-type="media">S5</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>Structural properties of APOA5-WT and APOA5-MUT. The number of hydrogen bonds (H-bonds) within the complex (<bold>A</bold>) and between individual chains (<bold>B</bold>). The SASA with a probe size of 0.14&#x02009;nm (<bold>C</bold>). The angle along the helical length of APOA5 was calculated to highlight the bendability of APOA5 (<bold>D</bold>). Box plots show the first and third quartile with the median line and mean-marker inside; minimum and maximum values are indicated with lines; outliers are indicated by round markers at the top and bottom of the box. The time-evolved quantities of these analyses are given in Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S5</xref>.</p></caption><graphic xlink:href="41598_2019_44699_Fig4_HTML" id="d29e1716"/></fig></p></sec><sec id="Sec4"><title>Distance and contact density between APOA5 monomers</title><p id="Par14">Given that the mutated protein has a different number of H-bonds and has different root mean square fluctuation (RMSF) values as compared with the WT, we wanted to determine the distance between individual monomers and their relative contacts. The minimum difference between the monomers and the average distance between the centres of mass (COMs) of these monomers were calculated. The results showed that APOA5-WT has a longer average distance between the COMs of its monomers as compared with APOA5-MUT (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5A</xref>). APOA5-MUT was restricted to a shorter range. Similarly, the average number of contacts was lower in APOA5-WT than in the mutant (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5B</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>The effect of mutation (G185C) on chain separation. (<bold>A</bold>) The minimum distance between the chains and the average distance between the COMs. (<bold>B</bold>) The number of contacts between the individual chains and COM distance. APOA5-WT showed a COM distance from 2.3 to 2.5&#x02009;nm with fewer contacts; by contrast, APOA5-MUT showed restricted chain separation, which might have allowed it to establish more contacts.</p></caption><graphic xlink:href="41598_2019_44699_Fig5_HTML" id="d29e1742"/></fig></p></sec><sec id="Sec5"><title>Different correlated movements between APOA5-WT and APOA5-MUT</title><p id="Par15">Because of the single amino acid change, many striking changes in the properties of the APOA5 complex were observed. Therefore, further analyses were performed to gain an in-depth understanding of structural alterations. To this end, we performed principal component analysis (PCA) on APOA5; the results showed uniform clustering of protein coordinates when PC1/PC2 and PC2/PC3 were compared. PC1/PC3 indicated some different metastable states that had low energy barriers. On the other hand, in the APOA5-MUT complex, the PC1/PC3 comparison did not reveal any significant differences. Furthermore, both PC1/PC2 and PC2/PC3 assumed two metastable states with a higher energy barrier as compared with APOA5-WT (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Based on these results, it is evident that APOA5-WT is more flexible than APOA5-MUT and has greater conformational space.<fig id="Fig6"><label>Figure 6</label><caption><p>Conformational sampling by PCA. PCA was performed on C&#x003b1; atoms for 500 snapshots from the last 10&#x02009;ns using Bio3D library in R v3.2.5. The colours (from blue to white to red) indicate the time of sampling. Continuous coloured dots indicate periodic jumps among these clusters, while a gap between the dots denotes an energy barrier.</p></caption><graphic xlink:href="41598_2019_44699_Fig6_HTML" id="d29e1759"/></fig></p><p id="Par16">When cross-correlation among amino acid residues was plotted, no substantial differences between the two systems were detected; however, several local correlative movements were observed. In general, APOA5-WT showed more non-correlative behaviour than APOA5-MUT, whereas APOA5-MUT manifested strong positive or negative correlative movements (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). In addition, this result implied that the mutant complex made restricted and stiffer movements.<fig id="Fig7"><label>Figure 7</label><caption><p>The dynamic cross-correlation matrix. Positive (red) and negative (blue) correlations are defined based on the relative movements of the residues; positive means movement in the same direction, and negative represents the movement in the opposite direction; uncorrelated movement (indicated by white colour) is defined as residue movement that does not influence the movement of others. The diagonal line indicates self-correlation, which is 1.0. This matrix is symmetric; therefore, the lower and upper halves are identical.</p></caption><graphic xlink:href="41598_2019_44699_Fig7_HTML" id="d29e1773"/></fig></p></sec></sec><sec id="Sec6" sec-type="discussion"><title>Discussion</title><p id="Par17">In this study, we identified 13 SNPs in a gene cluster, which are independently associated with plasma TG levels. Next, we performed computational analysis of rs2075191, the only SNP that is in a protein-coding region. Our results are in agreement with other reports, about Hong Kong and Guangzhou Chinese subjects. These reports suggested that SNP rs651821 in the promoter region of the <italic>APOA5</italic> gene is significantly associated with TG levels<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Our current data also provide strong evidence of associations between the four SNPs, including rs651821, and plasma TG levels among 12,523 individuals in Korea. Furthermore, these results indicated that plasma TG levels may be affected by cumulative effects of multiple variants. Therefore, this highly associative region should be further examined for clinical applications to more precisely define functional variants.</p><p id="Par18">Various studies have revealed that the <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> gene cluster is associated with increased plasma TG levels<sup><xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref></sup>. Results from our study also point to a significant statistical association between this locus and increased plasma TG levels. When these variants were analysed together in our haplotype analysis, three haplotypes (CCACGA, TCACGA, and CCCCGA) showed a strong association with hypertriglyceridaemia. Haplotypes that are associated with higher plasma TG levels involve the risk allele of rs651821 (C); the haplotype that posed the highest risk of elevated plasma TG levels included two risk alleles, rs651821 (C) and rs2075291 (A). As described in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, the associations of increased plasma TG levels with rs651821 and rs2075291 were significant and independent of each other. This result suggested that major effects on plasma TG levels may be exerted by the two SNPs: rs651821 and rs2075291.</p><p id="Par19">The aim of our study was to determine the number of genes and functional variants that are involved in TG regulation. Accordingly, we found both harmful and protective variants in the gene cluster that regulates plasma TG levels. The <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> gene cluster located in the 11q23.3 chromosomal region encodes a lipoprotein gene: <italic>APOA5</italic>. Therefore, it is rational to assume that <italic>APOA5</italic> is the likely candidate gene that gives rise to these functional variants. Various studies on people of different ancestries have confirmed that <italic>APOA5</italic> (rs2075291 and rs651821) variants are associated with changes in plasma TG levels<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>. The nonsynonymous variant in the <italic>APOA5</italic> coding region (rs2075291, G185C) is mostly found in the Asian population. This specific phenomenon is caused by differences in MAFs between ethnic populations (1% in Caucasians and 7% in Koreans)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Nonetheless, the precise functions of <italic>BUD13</italic>, <italic>ZNF259</italic>, and <italic>SIK3</italic> in TG regulation are unclear. BUD13 is one of the subunits of the splicing factor that participates in nuclear pre-mRNA retention<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, and ZNF259 is a regulatory protein that is associated with signal transduction and cell proliferation<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. SIK3 mediates inhibitory effects of cAMP<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Nevertheless, <italic>BUD13</italic>, <italic>ZNF259</italic>, and <italic>SIK3</italic> have been reported to be associated with TG levels in many GWASs in both European and Asian populations<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Furthermore, Aung <italic>et al</italic>. have reported that <italic>ZNF259</italic> and <italic>BUD13</italic> are associated with TG levels in two different Chinese populations and showed ethnic or sex specificity<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. The 13 SNPs of this gene cluster are located in noncoding, exon, and intergenic regions. Transcriptional binding sites of nearby genes contribute to transcriptional mechanisms influenced by these SNPs without being directly associated with protein regulation. By contrast, rs2075291 in APOA5 can directly influence the function and structure of APOA5 by offering an opportunity for an additional disulphide bond.</p><p id="Par20">The addition of an extra cysteine in APOA5 can lead to formation of other disulphide bonds with plasma proteins, especially with fibronectin and kininogen-1<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. This additional bond formation can limit its proper functions. A GWAS on the Taiwanese population uncovered a significant association between this polymorphism and hypertriglyceridaemia (P&#x02009;&#x0003c;&#x02009;0.001). The increased risk of hypertriglyceridaemia correlated in our study with CC homozygosity; the mean value of TG plasma concentration was low in G185 homozygotes (1.06&#x02009;mmol/L), moderate in G185C heterozygotes (1.22&#x02009;mmol/L), and high in C185 homozygotes (21.0&#x02009;mmol/L). There is a &#x0003e;10-fold higher risk of hypertriglyceridaemia in CC homozygotes<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. Therefore, CC homozygosity significantly correlates with hypertriglyceridaemia. It has also been observed that APOA5-MUT forms multimers <italic>in vitro</italic>; however, it remains monomeric <italic>in vivo</italic>. The nature of this mutation could lead to drastic changes in APOA5 function and conformation due to the position of the mutated glycine in the protein. Of note, there is no difference in the binding of APOA5-MUT to its receptor, LR8, and to low-density lipoprotein receptor-related protein 1 (LRP1)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, which suggests that the mutation may affect LPL activation rather than binding. Similarly, MD simulation showed that the mutated protein has stable structure, with differential H-bonding networks, SASA, and contact density that could affect the overall function of the complex rather binding (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). Furthermore, the intact 3D structure was also found to be comparable to previous observations<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup> (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>).</p><p id="Par21">The G185C mutation may lead to structural stiffness, as revealed by RMSF (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>), by lesser bending (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4D</xref>), and the average distance between the monomers and contact density (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). These types of structural rigidity can significantly alter the resulting APOA5&#x02013;receptor complex and reduce activation<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. Similarly, PCA uncovered the existence of energy barriers for various conformations in APOA5-MUT (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>); these barriers could result in differential correlated motion (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). In our model, both systems (APOA5-WT and APOA5-MUT) behaved similarly, as corroborated by the observation that mutated APOA5 binds to its receptor but is unable to initiate the signalling cascade<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. This binding means that the structure of APOA5 was intact after the mutation; there are subtle conformational changes that resulted in different bonding patterns. Similarly, there might be a few lost hydrogen bonds; this change prevented its proper binding and subsequent receptor activity initiation. In this scenario, our MD simulation results nicely corroborate the experimental results, and further highlight the allosteric nature of protein functions<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>.</p><p id="Par22">By association analysis and molecular modelling, we identified several SNPs in the <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> gene cluster that are associated with plasma TG levels in two Korean cohorts. We expect that this finding will help to develop a diagnostic tool for hypertriglyceridaemia, form the basis of functional analysis, and highlight the significance of the <italic>BUD13</italic>-<italic>ZNF259</italic>-<italic>APOA5</italic>-<italic>APOA1</italic>-<italic>SIK3</italic> gene cluster in hypertriglyceridaemia aetiology. In addition, our results suggest that mutated APOA5 might be a potential therapeutic target for TG regulation.</p></sec><sec id="Sec7"><title>Methods</title><sec id="Sec8"><title>Data sources</title><p id="Par23">We used two independent cohorts in Korea. A total of 3,695 individuals from the Health Examinee (HEXA) study served as the discovery dataset. The Korea Association Resource study (KARE) includes 8,842 individuals from the replication study. The large-scale HEXA study included middle-aged and elderly individuals between 40 and 70 years of age; data were collected in 2004 from participating hospitals, and the study was led by the Korean National Institute of Health. Genome-wide markers were validated in 3,695 participants; six participants whose plasma TG levels were not measured were excluded from analysis. Prospective cohort study KARE was initiated as part of the Korean genome epidemiology study in rural Ansung and urban Ansan in 2001. This study included 10,038&#x02009;healthy participants between 40 and 69 years of age. Both geographical regions are located in the Gyeonggi Province adjacent to Seoul. Information on the health status and health-related behaviours of the participants was collected through standardised questionnaire surveys. Blood samples were drawn from the antecubital vein following an 8 h fast. Plasma TG levels were measured by an enzymatic method, which was standardised by a centralised laboratory. Genome-wide data were validated in 8,840 participants. Six participants were excluded from the study at the time of analysis because two of them did not undergo measurement of plasma TG levels, and the other four participants did not measure body weight, whereas data obtained from rest of the 8,834 participants were used for the analysis. Detailed explanations of KARE have been reported in other studies<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. The information about KoGES (Korean Genome Epidemiology Study) can be viewed at [<ext-link ext-link-type="uri" xlink:href="http://www.nih.go.kr/NIH/eng/main.jsp">http://www.nih.go.kr/NIH/eng/main.jsp</ext-link> &#x0003e;&#x02009;Research infrastructure&#x02009;&#x0003e;&#x02009;KoGES]. The detailed cohort profile has been reported in another study<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p><p id="Par24">All individuals voluntarily participated in this study, and all the participants provided written informed consent. The study was conducted in accordance with the guidelines authorised by the Ethics Committee of KoGES at the Korean National Institute of Health. The protocol used for this project was approved by the Institutional Review Board (IRB) of Ajou University (201612-HB-002).</p></sec><sec id="Sec9"><title>Measurement of anthropometric and biochemical parameters</title><p id="Par25">The BMI was calculated (weight divided by height squared, kg/m<sup>2</sup>), followed by the measurement of body weight and height via standard methods in light clothing. The circulation levels of TG, TCHL, and glucose were measured after a 12&#x02009;h fast on a Hitachi 747 chemistry analyser (Hitachi Ltd, Tokyo, Japan).</p></sec><sec id="Sec10"><title>Quality control (QC) and genotyping</title><p id="Par26">Both studies used genome-wide condensed SNP marker analysis; HEXA used the Affymetrix Genome-Wide Human SNP Array GeneChip 6.0, and KARE utilised the Affymetrix Genome-Wide Human SNP Array GeneChip 5.0. For HEXA, markers with significant deviation from the Hardy&#x02013;Weinberg equilibrium (P&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;6</sup>), missing genotype rate over 5%, and MAF &#x0003c;0.01 were excluded; the remaining 627,659 markers were examined. Based on the same criteria as described above, 352,228 markers were used for analysis of KARE data. Imputation in HEXA was performed by means of IMPUTE2 (<ext-link ext-link-type="uri" xlink:href="http://mathgen.stats.ox.ac.uk/impute/impute.html">http://mathgen.stats.ox.ac.uk/impute/impute.html</ext-link>)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> and SHAPEIT software (<ext-link ext-link-type="uri" xlink:href="https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit.html">https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit.html</ext-link>)<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Using 1000 Genomes Project&#x02019;s haplotype phase I in NCBI build 37 (hg19), only markers with imputation certainty score &#x0003e;0.9 were chosen for subsequent analysis. In KARE, the reference panel originated from the 1000 Genomes Project&#x02019;s haplotype phase I in NCBI build 37 (hg19). As a result of imputation, 4,166,520 and 3,512,376 markers were selected from KARE and HEXA, respectively.</p></sec><sec id="Sec11"><title>Statistical analysis</title><p id="Par27">The effects of genotypes on plasma TG levels were evaluated via mixed linear models with adjustment for age, sex, and the BMI. For our association study, statistical analysis was performed in the PLINK software<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. TG&#x02013;SNP associations as well as their concomitant betas and conditional analysis were assessed using the GCTA software<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. In the conditional analysis, a stepwise model selection procedure was performed to select independently associated SNPs. Haplotype analysis was conducted by means of the haplo.stats package in the R software, version 3.4.1 (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Haplotypes with frequencies &#x0003c;0.01 were excluded from the analysis. LD matrix analysis for CHB&#x02009;+&#x02009;JPT and CEU was carried out in LDlink (<ext-link ext-link-type="uri" xlink:href="https://analysistools.nci.nih.gov/LDlink/">https://analysistools.nci.nih.gov/LDlink/</ext-link>)<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Box plots were constructed and <italic>P</italic> values were calculated using the SPSS 24 software (SPSS Inc., Chicago, Illinois).</p></sec><sec id="Sec12"><title>Molecular modelling and MD simulation</title><p id="Par28">Because there was no crystal structure available, a 3D model of APOA5 was created through different protocols including homology modelling and threading. For the homology model, the protein sequence of APOA5 was searched against the Protein Data Bank (PDB) database by means of the protein-BLAST tool with default parameters. APOA-IV (PDB code 3S84<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>) was found to have approximately 30% identity and 51% sequence similarity (without 84 N-terminal and 42 C-terminal residues) and belongs to the same family as APOA5. Furthermore, the sequence of APOA-5 was aligned against the available template of APOA-IV (3S83) in Clustal Omega<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, and a homology model was built for amino acid residues 78&#x02013;343; energy was minimised using the homology modelling suite in Molecular Operating Environment (MOE) (Chemical Computing Group, Montreal) and MODELLER<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> v9.17. To complete the model, we tried to build N- and C-terminal parts by ab initio methods, but it was challenging to adjust the relative orientation of those parts, and MODELLER lacks this capability. Because our desired polymorphic region falls into the modelled region, we focused on this region. Furthermore, model quality was evaluated on the ProSA web server<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> and the Ramachandran plot (&#x0003e;97% residues were in the allowed region, and only 11 residues were outliers). We found that homology models from MOE yielded better-quality models that kept their 3D structure after energy minimisation and were better suited for dimeric forms. For threading-based modelling, I-TASSER<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> was employed for the whole protein sequence. Nonetheless, the resultant models were either non-biological or of poor quality. Therefore, we proceeded with the homology models.</p><p id="Par29">Docking simulations were performed by means of PatchDock<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>, Rosie Dock<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, and MOE docking suites. We used a reference dimer structure as the literature suggested because this protein forms a multimeric biological entity<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. The resulting docking solutions were cross-validated via the following criteria: (1) the dimer should be anti-parallel so that the monomers fit snugly to each other, (2) and the position of C185 with respect to the dimer. Among the top 10 poses, the number of anti-parallel poses was greater (&#x0003e;60%) in each docking experiment. The anti-parallel poses were further evaluated for possible disulphide bond formation. We noted that C185 was consistently on the outer edge of the dimer and this arrangement allows it to form potential disulphide bonds with other proteins. To generate the final dimer model, a combination of algorithms (such as MOE, PatchDock, and Rosie Dock), and a literature search<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup> were utilised. After careful evaluation of docking poses, a final model was selected that showed lesser C&#x003b1;-RMSD (root-mean square deviation) relative to that of 3S84 (3.27&#x02009;&#x000c5; for C&#x003b1;), and we termed this model as APOA5-WT. APOA5-MUT was created by substituting G185 with cysteine, and both complexes were then studied by MD simulations.</p></sec><sec id="Sec13"><title>MD simulations</title><p id="Par30">These simulations were performed via the CHARMm22 (with CMAP correction)<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> forcefield definition in GROMACS<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> v2018.1. A dodecahedron box was created around the proteins, filled with the TIP3P water model<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, and neutralised with the counter-ions Na<sup>+</sup> and Cl<sup>&#x02212;</sup>; and adjusted the ionic concentration of 0.1&#x02009;M. The systems were energy-minimised through the steepest descent, and if a system did not converge to &#x0003c;10&#x02009;kJ&#x02009;&#x000b7;&#x02009;mol<sup>&#x02212;1</sup>&#x02009;&#x000b7;&#x02009;nm<sup>&#x02212;1</sup>, a conjugate gradient with a step size of 0.01&#x02009;nm was applied. The systems were then equilibrated in a two-step manner. During the first 100&#x02009;ps, temperature was equilibrated at 300&#x02009;K by the V-Rescale algorithm<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. The second step involved pressure equilibration at 1&#x02009;atm via the Parrinello&#x02013;Rahman algorithm<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. At both steps, all atoms were restrained to avoid any physical distortion.</p><p id="Par31">During production simulations, for integrating Newton&#x02019;s equation, the leap-frog integrator was used; only H-bonds were restrained by means of LINCS<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. A 1.2&#x02009;nm cut-off for short-range electrostatics and Van der Waals forces were applied, with force switches at 1.0&#x02009;nm. The particle mesh Ewald method was employed for calculating long-range electrostatics<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. For both systems, two independent simulations were carried out at different starting velocities, and the results were the average of these simulation runs. The coordinates and energy terms after every 2&#x02009;ps were saved for analysis, which was mostly carried out with GROMACS built-in tools. Nevertheless, PCA plots and dynamic cross-correlation matrix were created via the Bio3D library<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> in the R software. Figures were created in PyMol viewer (The PyMOL Molecular Graphics System, Version 1.7.4 Schr&#x000f6;dinger, LLC), and charts were created in Xmgrace and MS Excel (2016).</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec14"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2019_44699_MOESM1_ESM.pdf"><caption><p>Supporting Information</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-019-44699-x.</p></sec><ack><title>Acknowledgements</title><p>This study was conducted with bioresources from the National Biobank of Korea, the Centers for Disease Control and Prevention, Republic of Korea. This work was supported by the National Research Foundation of Korea (2019R1H1A2039674) and the Commercializations Promotion Agency for R&#x00026;D Outcomes funded by the Ministry of Science and ICT (2018K000369). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>H.K.K. and S.C. designed the study, H.K.K. and M.A.A. conducted the experiments, S.C. contributed reagents, H.K.K., M.A.A. and S.C. wrote the manuscript. All the coauthors approved the final manuscript.</p></notes><notes notes-type="COI-statement"><title>Competing Interests</title><p id="Par32">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>Banting lecture 1988. Role of insulin resistance in human disease</article-title><source>Diabetes</source><year>1988</year><volume>37</volume><fpage>1595</fpage><lpage>1607</lpage><pub-id pub-id-type="doi">10.2337/diab.37.12.1595</pub-id><pub-id pub-id-type="pmid">3056758</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmalayam</surname><given-names>I</given-names></name><name><surname>Suto</surname><given-names>M</given-names></name></person-group><article-title>Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy</article-title><source>Current pharmaceutical design</source><year>2013</year><volume>19</volume><fpage>5755</fpage><lpage>5763</lpage><pub-id pub-id-type="doi">10.2174/13816128113199990360</pub-id><pub-id pub-id-type="pmid">23448486</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genetic and environmental contributions to phenotypic components of metabolic syndrome: a population-based twin study</article-title><source>Obesity (Silver Spring)</source><year>2009</year><volume>17</volume><fpage>1581</fpage><lpage>1587</lpage><pub-id pub-id-type="doi">10.1038/oby.2009.125</pub-id><pub-id pub-id-type="pmid">19407809</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannel</surname><given-names>WB</given-names></name><name><surname>Dawber</surname><given-names>TR</given-names></name><name><surname>Kagan</surname><given-names>A</given-names></name><name><surname>Revotskie</surname><given-names>N</given-names></name><name><surname>Stokes</surname><given-names>J</given-names><suffix>III.</suffix></name></person-group><article-title>Factors of risk in the development of coronary heart disease&#x02013;six year follow-up experience. The Framingham Study</article-title><source>Annals of internal medicine</source><year>1961</year><volume>55</volume><fpage>33</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-55-1-33</pub-id><pub-id pub-id-type="pmid">13751193</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Sharma, R. In <italic>Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease</italic> (ed. Preedy, V. R.) 623&#x02013;655 (Academic Press, 2013).</mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">In <italic>Rosenberg&#x02019;s Molecular and Genetic Basis of Neurological and Psychiatric Disease</italic> (<italic>Fifth Edition</italic>) (ed. Pascual, J. M.) i&#x02013;iii (Academic Press, 2015).</mixed-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garelnabi</surname><given-names>M</given-names></name><name><surname>Lor</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Chai</surname><given-names>F</given-names></name><name><surname>Santanam</surname><given-names>N</given-names></name></person-group><article-title>The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research</article-title><source>Clinical biochemistry</source><year>2013</year><volume>46</volume><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2012.09.007</pub-id><?supplied-pmid 23000317?><pub-id pub-id-type="pmid">23000317</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vliet</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice</article-title><source>Biochemical and biophysical research communications</source><year>2002</year><volume>295</volume><fpage>1156</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1016/S0006-291X(02)00808-2</pub-id><pub-id pub-id-type="pmid">12135615</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins</article-title><source>Clinical chemistry</source><year>2005</year><volume>51</volume><fpage>351</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2004.040824</pub-id><?supplied-pmid 15528295?><pub-id pub-id-type="pmid">15528295</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennacchio</surname><given-names>LA</given-names></name><etal/></person-group><article-title>An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>169</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1126/science.1064852</pub-id><?supplied-pmid 11588264?><pub-id pub-id-type="pmid">11588264</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia</article-title><source>Nature clinical practice. Cardiovascular medicine</source><year>2008</year><volume>5</volume><fpage>730</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1038/ncpcardio1326</pub-id><?supplied-pmid 18779834?><pub-id pub-id-type="pmid">18779834</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willer</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Newly identified loci that influence lipid concentrations and risk of coronary artery disease</article-title><source>Nature genetics</source><year>2008</year><volume>40</volume><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1038/ng.76</pub-id><?supplied-pmid 18193043?><pub-id pub-id-type="pmid">18193043</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teslovich</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Biological, clinical and population relevance of 95 loci for blood lipids</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/nature09270</pub-id><?supplied-pmid 3039276?><pub-id pub-id-type="pmid">20686565</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><etal/></person-group><article-title>A genome wide association study identifies common variants associated with lipid levels in the Chinese population</article-title><source>PloS One</source><year>2013</year><volume>8</volume><fpage>e82420</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0082420</pub-id><?supplied-pmid 24386095?><pub-id pub-id-type="pmid">24386095</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willer</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Discovery and refinement of loci associated with lipid levels</article-title><source>Nature genetics</source><year>2013</year><volume>45</volume><fpage>1274</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1038/ng.2797</pub-id><?supplied-pmid 24097068?><pub-id pub-id-type="pmid">24097068</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>TR</given-names></name><etal/></person-group><article-title>A replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglycerides</article-title><source>PloS One</source><year>2012</year><volume>7</volume><fpage>e37056</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0037056</pub-id><?supplied-pmid 22623978?><pub-id pub-id-type="pmid">22623978</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>A</given-names></name><etal/></person-group><article-title>Amerindian-specific regions under positive selection harbour new lipid variants in Latinos</article-title><source>Nature communications</source><year>2014</year><volume>5</volume><fpage>3983</fpage><pub-id pub-id-type="doi">10.1038/ncomms4983</pub-id><?supplied-pmid 24886709?><pub-id pub-id-type="pmid">24886709</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>G</given-names></name><etal/></person-group><article-title>A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency</article-title><source>Journal of the American College of Cardiology</source><year>2014</year><volume>64</volume><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2014.03.050</pub-id><?supplied-pmid 25034063?><pub-id pub-id-type="pmid">25034063</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>V</given-names></name><etal/></person-group><article-title>Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291)</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><year>2014</year><volume>34</volume><fpage>2254</fpage><lpage>2260</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.114.304027</pub-id><?supplied-pmid 25127531?><pub-id pub-id-type="pmid">25127531</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>MT</given-names></name><name><surname>Jonson</surname><given-names>PH</given-names></name><name><surname>Petersen</surname><given-names>SB</given-names></name></person-group><article-title>Amino acid neighbours and detailed conformational analysis of cysteines in proteins</article-title><source>Protein Eng.</source><year>1999</year><volume>12</volume><fpage>535</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1093/protein/12.7.535</pub-id><pub-id pub-id-type="pmid">10436079</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>CQ</given-names></name><etal/></person-group><article-title>A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese</article-title><source>European journal of human genetics: EJHG</source><year>2010</year><volume>18</volume><fpage>1255</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2010.93</pub-id><?supplied-pmid 20571505?><pub-id pub-id-type="pmid">20571505</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Common variants at 30 loci contribute to polygenic dyslipidemia</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/ng.291</pub-id><pub-id pub-id-type="pmid">19060906</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans</article-title><source>Nat. Genet.</source><year>2008</year><volume>40</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/ng.75</pub-id><?supplied-pmid 2682493?><pub-id pub-id-type="pmid">18193044</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Chien</surname><given-names>KL</given-names></name><name><surname>Chen</surname><given-names>MF</given-names></name><name><surname>Stephenson</surname><given-names>DA</given-names></name><name><surname>Su</surname><given-names>TC</given-names></name></person-group><article-title>Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia</article-title><source>Clin. Chim. Acta</source><year>2013</year><volume>416</volume><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2012.10.054</pub-id><?supplied-pmid 23178747?><pub-id pub-id-type="pmid">23178747</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Influences of APOA5 variants on plasma triglyceride levels in Uyghur population</article-title><source>PloS One</source><year>2014</year><volume>9</volume><fpage>e110258</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0110258</pub-id><?supplied-pmid 25313938?><pub-id pub-id-type="pmid">25313938</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guardiola</surname><given-names>M</given-names></name><etal/></person-group><article-title>APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis</article-title><source>Atherosclerosis</source><year>2015</year><volume>240</volume><fpage>98</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2015.03.008</pub-id><?supplied-pmid 25770687?><pub-id pub-id-type="pmid">25770687</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gombojav</surname><given-names>B</given-names></name><etal/></person-group><article-title>Multiple susceptibility loci at chromosome 11q23.3 are associated with plasma triglyceride in East Asians</article-title><source>J. Lipid Res.</source><year>2016</year><volume>57</volume><fpage>318</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1194/jlr.P063461</pub-id><?supplied-pmid 26634697?><pub-id pub-id-type="pmid">26634697</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Structure of the yeast Pml1 splicing factor and its integration into the RES complex</article-title><source>Nucleic Acids Res.</source><year>2009</year><volume>37</volume><fpage>129</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn894</pub-id><?supplied-pmid 19033360?><pub-id pub-id-type="pmid">19033360</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galcheva-Gargova</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor</article-title><source>Science</source><year>1996</year><volume>272</volume><fpage>1797</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1126/science.272.5269.1797</pub-id><pub-id pub-id-type="pmid">8650580</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonntag</surname><given-names>T</given-names></name><name><surname>Vaughan</surname><given-names>JM</given-names></name><name><surname>Montminy</surname><given-names>M</given-names></name></person-group><article-title>14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs)</article-title><source>The FEBS journal</source><year>2018</year><volume>285</volume><fpage>467</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1111/febs.14351</pub-id><?supplied-pmid 29211348?><pub-id pub-id-type="pmid">29211348</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><fpage>684</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/ng.628</pub-id><?supplied-pmid 20657596?><pub-id pub-id-type="pmid">20657596</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aung</surname><given-names>LH</given-names></name><etal/></person-group><article-title>Association between the MLX interacting protein-like, BUD13 homolog and zinc finger protein 259 gene polymorphisms and serum lipid levels</article-title><source>Sci. Rep.</source><year>2014</year><volume>4</volume><fpage>5565</fpage><pub-id pub-id-type="doi">10.1038/srep05565</pub-id><?supplied-pmid 24989072?><pub-id pub-id-type="pmid">24989072</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aung</surname><given-names>LH</given-names></name><etal/></person-group><article-title>Sex-specific association of the zinc finger protein 259 rs2075290 polymorphism and serum lipid levels</article-title><source>Int. J. Med. Sci.</source><year>2014</year><volume>11</volume><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.7150/ijms.8489</pub-id><?supplied-pmid 24688311?><pub-id pub-id-type="pmid">24688311</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>JT</given-names></name><name><surname>Wen</surname><given-names>HC</given-names></name><name><surname>Chien</surname><given-names>KL</given-names></name><name><surname>Hsu</surname><given-names>HC</given-names></name><name><surname>Lin</surname><given-names>SW</given-names></name></person-group><article-title>A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia</article-title><source>Human Molecular Genetics</source><year>2003</year><volume>12</volume><fpage>2533</fpage><lpage>2539</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg255</pub-id><?supplied-pmid 12915450?><pub-id pub-id-type="pmid">12915450</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubacek</surname><given-names>JA</given-names></name><etal/></person-group><article-title>New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels</article-title><source>Physiological Research</source><year>2004</year><volume>53</volume><fpage>225</fpage><lpage>228</lpage><?supplied-pmid 15046561?><pub-id pub-id-type="pmid">15046561</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorfmeister</surname><given-names>B</given-names></name><etal/></person-group><article-title>Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on <italic>in vitro</italic> lipoprotein lipase activity and receptor binding</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2008</year><volume>28</volume><fpage>1866</fpage><lpage>1871</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.108.172866</pub-id><?supplied-pmid 18635818?><pub-id pub-id-type="pmid">18635818</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza-Barbera</surname><given-names>E</given-names></name><etal/></person-group><article-title>Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia</article-title><source>J. Lipid Res.</source><year>2013</year><volume>54</volume><fpage>649</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1194/jlr.M031195</pub-id><?supplied-pmid 23307945?><pub-id pub-id-type="pmid">23307945</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0129488</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0129488</pub-id><?supplied-pmid 26079787?><pub-id pub-id-type="pmid">26079787</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naganathan</surname><given-names>AN</given-names></name></person-group><article-title>Modulation of allosteric coupling by mutations: from protein dynamics and packing to altered native ensembles and function</article-title><source>Current opinion in structural biology</source><year>2018</year><volume>54</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2018.09.004</pub-id><?supplied-pmid 30268910?><pub-id pub-id-type="pmid">30268910</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinkam</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Pons</surname><given-names>J</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name></person-group><article-title>Impact of mutations on the allosteric conformational equilibrium</article-title><source>J Mol Biol</source><year>2013</year><volume>425</volume><fpage>647</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2012.11.041</pub-id><?supplied-pmid 23228330?><pub-id pub-id-type="pmid">23228330</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits</article-title><source>Nat. Genet.</source><year>2011</year><volume>43</volume><fpage>990</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1038/ng.939</pub-id><?supplied-pmid 21909109?><pub-id pub-id-type="pmid">21909109</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YS</given-names></name><etal/></person-group><article-title>A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>527</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/ng.357</pub-id><?supplied-pmid 19396169?><pub-id pub-id-type="pmid">19396169</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>BG</given-names></name></person-group><article-title>Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium</article-title><source>International journal of epidemiology</source><year>2017</year><volume>46</volume><fpage>e20</fpage><pub-id pub-id-type="doi">10.1093/ije/dyv316</pub-id><?supplied-pmid 27085081?><pub-id pub-id-type="pmid">27085081</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howie</surname><given-names>BN</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name><name><surname>Marchini</surname><given-names>J</given-names></name></person-group><article-title>A flexible and accurate genotype imputation method for the next generation of genome-wide association studies</article-title><source>PLoS Genet.</source><year>2009</year><volume>5</volume><fpage>e1000529</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1000529</pub-id><?supplied-pmid 19543373?><pub-id pub-id-type="pmid">19543373</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname><given-names>J</given-names></name><etal/></person-group><article-title>A general approach for haplotype phasing across the full spectrum of relatedness</article-title><source>PLoS genetics</source><year>2014</year><volume>10</volume><fpage>e1004234</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1004234</pub-id><?supplied-pmid 24743097?><pub-id pub-id-type="pmid">24743097</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><etal/></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title><source>Am. J. Hum. Genet.</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1086/519795</pub-id><?supplied-pmid 17701901?><pub-id pub-id-type="pmid">17701901</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Goddard</surname><given-names>ME</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name></person-group><article-title>GCTA: a tool for genome-wide complex trait analysis</article-title><source>Am. J. Hum. Genet.</source><year>2011</year><volume>88</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2010.11.011</pub-id><?supplied-pmid 21167468?><pub-id pub-id-type="pmid">21167468</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zaitlen</surname><given-names>NA</given-names></name><name><surname>Goddard</surname><given-names>ME</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name></person-group><article-title>Advantages and pitfalls in the application of mixed-model association methods</article-title><source>Nat. Genet.</source><year>2014</year><volume>46</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1038/ng.2876</pub-id><?supplied-pmid 24473328?><pub-id pub-id-type="pmid">24473328</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Wickham, H. <italic>ggplot2: elegant graphics for data analysis</italic>. (Springer, 2009).</mixed-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machiela</surname><given-names>MJ</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name></person-group><article-title>LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>3555</fpage><lpage>3557</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv402</pub-id><?supplied-pmid 26139635?><pub-id pub-id-type="pmid">26139635</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X</given-names></name><etal/></person-group><article-title>The structure of dimeric apolipoprotein A-IV and its mechanism of self-association</article-title><source>Structure</source><year>2012</year><volume>20</volume><fpage>767</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.str.2012.02.020</pub-id><?supplied-pmid 22579246?><pub-id pub-id-type="pmid">22579246</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chojnacki</surname><given-names>S</given-names></name><name><surname>Cowley</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Foix</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name></person-group><article-title>Programmatic access to bioinformatics tools from EMBL-EBI update: 2017</article-title><source>Nucleic acids research</source><year>2017</year><volume>45</volume><fpage>W550</fpage><lpage>W553</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx273</pub-id><?supplied-pmid 28431173?><pub-id pub-id-type="pmid">28431173</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eswar</surname><given-names>Narayanan</given-names></name><name><surname>Webb</surname><given-names>Ben</given-names></name><name><surname>Marti-Renom</surname><given-names>Marc A.</given-names></name><name><surname>Madhusudhan</surname><given-names>M.S.</given-names></name><name><surname>Eramian</surname><given-names>David</given-names></name><name><surname>Shen</surname><given-names>Min-yi</given-names></name><name><surname>Pieper</surname><given-names>Ursula</given-names></name><name><surname>Sali</surname><given-names>Andrej</given-names></name></person-group><article-title>Comparative Protein Structure Modeling Using Modeller</article-title><source>Current Protocols in Bioinformatics</source><year>2006</year><volume>15</volume><issue>1</issue><fpage>5.6.1-5.6.30</fpage><pub-id pub-id-type="doi">10.1002/0471250953.bi0506s15</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiederstein</surname><given-names>M</given-names></name><name><surname>Sippl</surname><given-names>MJ</given-names></name></person-group><article-title>ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins</article-title><source>Nucleic Acids Res.</source><year>2007</year><volume>35</volume><fpage>W407</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm290</pub-id><?supplied-pmid 17517781?><pub-id pub-id-type="pmid">17517781</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>I-TASSER server for protein 3D structure prediction</article-title><source>BMC Bioinformatics</source><year>2008</year><volume>9</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-9-40</pub-id><?supplied-pmid 18215316?><pub-id pub-id-type="pmid">18215316</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneidman-Duhovny</surname><given-names>D</given-names></name><name><surname>Inbar</surname><given-names>Y</given-names></name><name><surname>Nussinov</surname><given-names>R</given-names></name><name><surname>Wolfson</surname><given-names>HJ</given-names></name></person-group><article-title>PatchDock and SymmDock: servers for rigid and symmetric docking</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>W363</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1093/nar/gki481</pub-id><?supplied-pmid 15980490?><pub-id pub-id-type="pmid">15980490</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyskov</surname><given-names>S</given-names></name><name><surname>Gray</surname><given-names>JJ</given-names></name></person-group><article-title>The RosettaDock server for local protein-protein docking</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>W233</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn216</pub-id><?supplied-pmid 18442991?><pub-id pub-id-type="pmid">18442991</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M</given-names></name><etal/></person-group><article-title>A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients</article-title><source>PloS one</source><year>2017</year><volume>12</volume><fpage>e0186693</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0186693</pub-id><?supplied-pmid 29211729?><pub-id pub-id-type="pmid">29211729</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Davidson</surname><given-names>WS</given-names></name><name><surname>Thompson</surname><given-names>TB</given-names></name></person-group><article-title>Improving the diffraction of apoA-IV crystals through extreme dehydration</article-title><source>Acta crystallographica. Section F, Structural biology and crystallization communications</source><year>2012</year><volume>68</volume><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1107/S1744309111048706</pub-id><?supplied-pmid 22232185?><pub-id pub-id-type="pmid">22232185</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjelkmar</surname><given-names>P</given-names></name><name><surname>Larsson</surname><given-names>P</given-names></name><name><surname>Cuendet</surname><given-names>MA</given-names></name><name><surname>Hess</surname><given-names>B</given-names></name><name><surname>Lindahl</surname><given-names>E</given-names></name></person-group><article-title>Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models</article-title><source>J. Chem. Theory Comput.</source><year>2010</year><volume>6</volume><fpage>459</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1021/ct900549r</pub-id><?supplied-pmid 26617301?><pub-id pub-id-type="pmid">26617301</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title><source>SoftwareX</source><year>2015</year><volume>1&#x02013;2</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>WL</given-names></name><name><surname>Chandrasekhar</surname><given-names>J</given-names></name><name><surname>Madura</surname><given-names>JD</given-names></name></person-group><article-title>Comparison of simple potential functions for simulating liquid water</article-title><source>The Journal of Chemical Physics</source><year>1983</year><volume>79</volume><fpage>926</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1063/1.445869</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussi</surname><given-names>G</given-names></name><name><surname>Donadio</surname><given-names>D</given-names></name><name><surname>Parrinello</surname><given-names>M</given-names></name></person-group><article-title>Canonical sampling through velocity rescaling</article-title><source>J. Chem. Phys.</source><year>2007</year><volume>126</volume><fpage>014101</fpage><pub-id pub-id-type="doi">10.1063/1.2408420</pub-id><?supplied-pmid 17212484?><pub-id pub-id-type="pmid">17212484</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrinello</surname><given-names>M</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name></person-group><article-title>Crystal Structure and Pair Potentials: A Molecular-Dynamics Study</article-title><source>Phys. Rev. Lett.</source><year>1980</year><volume>45</volume><fpage>1196</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.45.1196</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berk</surname><given-names>H</given-names></name><name><surname>Henk</surname><given-names>B</given-names></name><name><surname>Berendsen</surname><given-names>HJC</given-names></name><name><surname>Fraaije</surname><given-names>JGEM</given-names></name></person-group><article-title>LINCS: A linear constraint solver for molecular simulations</article-title><source>Journal of Computational Chemistry</source><year>1997</year><volume>18</volume><fpage>1463</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199709)18:12&#x0003c;1463::AID-JCC4&#x0003e;3.0.CO;2-H</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darden</surname><given-names>T</given-names></name><name><surname>York</surname><given-names>D</given-names></name><name><surname>Pedersen</surname><given-names>L</given-names></name></person-group><article-title>Particle mesh Ewald: An N&#x022c5;log(N) method for Ewald sums in large systems</article-title><source>The Journal of chemical physics</source><year>1993</year><volume>98</volume><fpage>10089</fpage><lpage>10092</lpage><pub-id pub-id-type="doi">10.1063/1.464397</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skjaerven</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>XQ</given-names></name><name><surname>Scarabelli</surname><given-names>G</given-names></name><name><surname>Grant</surname><given-names>BJ</given-names></name></person-group><article-title>Integrating protein structural dynamics and evolutionary analysis with Bio3D</article-title><source>BMC Bioinformatics</source><year>2014</year><volume>15</volume><fpage>399</fpage><pub-id pub-id-type="doi">10.1186/s12859-014-0399-6</pub-id><?supplied-pmid 25491031?><pub-id pub-id-type="pmid">25491031</pub-id></element-citation></ref></ref-list></back></article>